SCHEMBL29659624

SCHEMBL29659624

CN(C)c1nc(NCc2ccco2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ YTHDC1 Q96MU7 1/20 0.48
▸ FLT3 P36888 4/20 0.46
▸ CCNE1 P24864 4/20 0.43
▸ CDK2 P24941 4/20 0.43
▸ CDK1 P06493 4/20 0.42
▸ CCNB2 O95067 1/20 0.42
▸ CCNB1 P14635 1/20 0.42
▸ CCNB3 Q8WWL7 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547186 1.00 NPC1 (0.52) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL29659742 0.97 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL20547431 0.97 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL20547207 0.92 NPC1 (0.51) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL20547205 0.89 SMN1; SMN2 (0.47) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL30675139 0.88 CCNE1 (0.53) FLT3CCNE1CDK2CDK1CCNB2
SCHEMBL29659534 0.87 YTHDC1 (0.55) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL20547188 0.87 YTHDC1 (0.55) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL20547610 0.86 NPC1 (0.52) NPC1RAB9ASMN1; SMN2YTHDC1FLT3
SCHEMBL29659648 0.86 NPC1 (0.52) NPC1RAB9ASMN1; SMN2YTHDC1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback